KYMR Kymera Therapeutics posts widerthanexpected Q4 2025 loss shares slide 259 after earnings release Does Hongli Group HLP stock justify its valuation In Focus 20260420 Is Silexion Therapeutics SLXN stock undervalued compared to fundamentals Q4 2025 Profit Disappoints How CanSolar CSIQ talent strategy drives results Q4 2025 Profit Disappoints ALUB AlussaEnergy latest quarterly earnings release withholds core financial metrics amid ongoing SPAC merger negotiations